Skip To Main Content
Jieying Qian on Muck Rack

Jieying Qian

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jieying

Contact Jieying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

ALP-Responsive Luminescent Nanosheets Promote Precise Hepatitis Theragnostic by Co-Targeting NLRP3 and Cholestasis

|
By Jieying Qian, Zhixin Wu, Xianwu Yan
| Wiley Online Library Verified
Jieying Qian, Zhixin Wu, and Xianwu Yan contributed equally to this work. J.Qian, Z.Wu, X.Yan, et al. “ALP-Responsive Luminescent Nanosheets Promote Precise Hepatitis Theragnostic by Co-Targeting NLRP3 and Cholestasis.” Advanced Materials (2026): e73312. https://doi.org/10.1002/adma.73312 Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.
Open in Who Shared Issue with article?

Autophagy‐Targeting Fe-Cu Nanozyme for Tumor Immune Microenvironment Remodeling and Image‐Guided Cancer Immunotherapy

|
By Chao Chen, Yu Liang, Xiaowan Huang, Jieying Qian
| Wiley Online Library Verified
1 Introduction Immunotherapy has revolutionized cancer treatment, yet tumor immune evasion and resistance remain formidable challenges driving disease progression.[1] Central to this is the suppressive tumor immune microenvironment (TIME), which recruits pro-tumor immune cells, depletes antigen-specific cytotoxic T lymphocytes (CTLs), and promotes antigen loss or mutation, thereby undermining therapeutic efficacy.[2] Targeting the TIME by modulating its cellular components has emerged as a...
Open in Who Shared Issue with article?

NIR Emissive Functional Nanoparticles Promote Precise Pancreatic Cancer Therapy by Co‐Targeting Mutant p53 and Oncogenic KRAS

|
By Jieying Qian, Zhenyu Yang, Wang Zhang, YaYi Ye
| Wiley Online Library Verified
Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description adfm202312610-sup-0001-SuppMat.pdf959.4 KB Supporting Information References 1a) , , Nat. Rev. Cancer 2016, 16, 553; b) , , , , , , , Ca-Cancer J. Clin. 2021, 71, 209. 2, , , , , , , J. Clin. Oncol. 2021, 39, 4. 3, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , et al., Science 2017, 357, 1156. 4, , , Cancer Cell 2020, 38, 788.
Open in Who Shared Issue with article?
See all 8 articles